Masmudur Mohammed Rahman

Assistant Professor

Arizona State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Masmudur Mohammed Rahman is an Assistant Professor at Arizona State University, USA. His research focuses on oncolytic virotherapy, immune modulation, and cancer treatment strategies, as highlighted in his recent articles, which explore the Myxoma virus and its potential applications in combating various cancers. His work also investigates novel therapeutic approaches against coronaviruses and the use of adipose-derived stem cells in enhancing treatment efficacy.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Brenda Hogue

Professor

Arizona State University

UNITED STATES

View details

Grant McFadden

Professor and Director of B-CIVV

Arizona State University

UNITED STATES

View details

Joanna Jazowiecka-Rakus

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masmudur Mohammed Rahman

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

The Role of Myxoma Virus Immune Modulators and Host Range Factors in Pathogenesis and Species Leaping

Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication

Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy

Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma

Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma

Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y<sub>MA30</sub> Strain of SARS-CoV-2.

Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma

Collaborators (3)

Brenda Hogue

Grant McFadden

Joanna Jazowiecka-Rakus

Make your next move.